Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 1.00 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.50 |
| ▸ | PNLIP | P16233 | 1/20 | 0.50 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.50 |
| ▸ | TOP1 | P11387 | 1/20 | 0.47 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | F10 | P00742 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Clioxanide SCHEMBL29358452 | 1.00 | POLB (1.00) | POLBNLRP3KMT2AMEN1HTT | |
| SCHEMBL20413309 | 0.88 | POLB (0.79) | POLBNLRP3KMT2AMEN1HTT | |
| SCHEMBL26176577 | 0.86 | POLB (0.76) | POLBNLRP3KMT2AMEN1HTT | |
| Clioxanide SCHEMBL5307331 | 0.86 | POLB (0.74) | POLBNLRP3KMT2AMEN1HTT | |
| SCHEMBL14223805 | 0.84 | POLB (0.72) | POLBNLRP3KMT2AMEN1HTT | |
| SCHEMBL14195181 | 0.81 | POLB (0.68) | POLBNLRP3TOP1ALDH1A1NR1H4 | |
| SCHEMBL14223829 | 0.81 | POLB (0.67) | POLBNLRP3KMT2AMEN1HTT | |
| SCHEMBL20413314 | 0.80 | POLB (0.67) | POLBNLRP3KMT2AMEN1TOP1 | |
| SCHEMBL14195174 | 0.78 | KMT2A (0.70) | POLBNLRP3KMT2AMEN1HTT | |
| SCHEMBL23095652 | 0.78 | POLB (0.64) | POLBNLRP3KMT2AMEN1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091043-A1 | COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIUM INFECTIONS | DATA2DISCOVERY INC (US) | 2026-04-02 | — | — | US | claimed |
| EP-4586826-A1 | FEED AND METHODS FOR CONTROLLING HEARTWORM INFECTIONS IN A MAMMAL | In the Bowl Animal Health, Inc. (US) | 2025-07-23 | — | — | EP | claimed |
| WO-2024064209-A1 | COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIUM INFECTIONS | DATA2DISCOVERY, INC. (US) | 2024-03-28 | — | — | WO | claimed |
| WO-2024059837-A1 | FEED AND METHODS FOR CONTROLLING HEARTWORM INFECTIONS IN A MAMMAL | IN THE BOWL ANIMAL HEALTH, INC. (US) | 2024-03-21 | — | — | WO | claimed |
| US-11166926-B2 | Compositions and methods for protecting a host from enteric toxigenic pathogens | THE HOSPITAL FOR SICK CHILDREN (CA) | 2021-11-09 | — | — | US | claimed |
| US-20210137948-A1 | TREATMENT OF INFECTIONS CAUSED BY NEISSERIA GONOCOCCUS USING A HALOGENATED SALICYLANILIDE | UNION therapeutics A/S (DK) | 2021-05-13 | — | — | US | claimed |
| EP-3773602-A1 | TREATMENT OF INFECTIONS CAUSED BY NEISSERIA GONOCOCCUS USING A HALOGENATED SALICYLANILIDE | UNION therapeutics A/S (DK) | 2021-02-17 | — | — | EP | claimed |
| US-20200046659-A1 | COMPOSITIONS AND METHODS FOR PROTECTING A HOST FROM ENTERIC TOXIGENIC PATHOGENS | UNIVERSITY OF MARYLAND, BALTIMORE | 2020-02-13 | — | — | US | claimed |
| US-10463680-B2 | Halogenated salicylanilides for treating clostridium infections | UNION therapeutics A/S (DK) | 2019-11-05 | — | — | US | claimed |
| WO-2019192968-A1 | TREATMENT OF INFECTIONS CAUSED BY NEISSERIA GONOCOCCUS USING A HALOGENATED SALICYLANILIDE | UNION therapeutics A/S (DK) | 2019-10-10 | — | — | WO | claimed |
| WO-2004006906-A2 | METHODS FOR THE TREATMENT OF NEOPLASMS | COMBINATORX, INCORPORATED (US) | 2004-01-22 | — | — | WO | claimed |
| CN-1386507-A | Compound antiparasitic medicine for fish or full-value feed containing antiparasitic medicine | WANG YUWAN (CN) | 2002-12-25 | — | — | CN | claimed |
| EP-0710105-A4 | SYNERGISTIC ANTHELMINTIC COMPOSITIONS | UNIV AUSTRALIAN (AU) | 1998-06-10 | — | — | EP | claimed |
| EP-0710105-A1 | SYNERGISTIC ANTHELMINTIC COMPOSITIONS | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 1996-05-08 | — | — | EP | claimed |
| WO-1994028887-A1 | SYNERGISTIC ANTHELMINTIC COMPOSITIONS | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 1994-12-22 | — | — | WO | claimed |
| US-4957494-A | Multi-layer delivery system | ALZA CORPORATION (US) | 1990-09-18 | — | — | US | claimed |
| US-4874388-A | Multi-layer delivery system | ALZA CORPORATION (US) | 1989-10-17 | — | — | US | claimed |
| EP-0059074-B1 | ANTHELMINTIC COMPOSITION AND THE USE THEREOF | SANKYO COMPANY LIMITED (JP) | 1984-10-10 | — | — | EP | claimed |
| US-4468390-A | Anthelmintic composition and the use thereof | SANKYO COMPANY, LIMITED (JP) | 1984-08-28 | — | — | US | claimed |
| EP-0059074-A1 | Anthelmintic composition and the use thereof | SANKYO COMPANY LIMITED (JP) | 1982-09-01 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10463680-B2 | Halogenated salicylanilides for treating clostridium infections | SLC10A2, FABP2, SI | POLB 3243/4885NLRP3 810/4885KMT2A 2484/4885 |
| US-20260091043-A1 | COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIUM INFECTIONS | AHCY, MACO1, ME3 | POLB 1888/4885NLRP3 83/4885KMT2A 3975/4885 |
| US-20210137948-A1 | TREATMENT OF INFECTIONS CAUSED BY NEISSERIA GONOCOCCUS USING A HALOGENATED SALICYLANILIDE | MGLL, NIT2, SI | POLB 1391/4885NLRP3 2299/4885KMT2A 4069/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.